samedan logo
 
 
 
spacer
home > ebr > Autumn 2019
PUBLICATIONS

European Biopharmaceutical Review

ebr
Autumn 2019

   
Text
PDF
bullet
In Brief
In Brief

Vax Populi

EBR’s Industry Advisor, Emile Bellott, discusses the health achievement of vaccinations against infectious diseases in the post-industrial era, and how immunisation is essential to continue saving millions of lives every year.

 
view
download pdf
bullet
Features
Anti-Idiotypic Antibodies

Robust Method Development for Biologics and Biosimilars

Amanda Turner at Bio-Rad Laboratories examines the factors that enable the demand for biological medicines to evolve and expand, such as the introduction of lower-cost biosimilars, or the ongoing identification of new drug targets.

 
view
download pdf
Preclinical Oncological Research

PET Technology and Tumour Progression

Dr Todd Sasser at Bruker BioSpin writes on how, with the advancements of PET scanning, oncologists are now better able to understand the development of cancers and tumours by better highlighting their morphology and other biomarkers.

 
view
download pdf
Accelerating Process Development

Simply Good Monitoring

Paul Kroll and Alexandra Hofer at Securecell AG articulate how digitisation can accelerate process development in relation to the analysis of liquid samples.
 
view
download pdf
High-Productivity Membrane Chromatography

The Next-Generation Purification of Monoclonal Antibodies

Gary Skarja at Merck examines the key developments in mAb manufacturing, including the benefits that address productivity and cost challenges in a singleuse format.

 
view
download pdf
Challenges in Cellular, Tissue, and Gene Therapy Products

Drug Development Decisions

Cost control in drug development is always at the forefront of manufacturer’s minds, and Zeb Younes and Zaklina Buljovcic at PharmaLex examine how automation and decentralising the manufacturing process can help achieve this goal in the long run.
 
view
download pdf
Developments in Artificial Intelligence

Focusing on Target Safety

Although in its infancy, Ruth Roberts at ApconiX describes how artificial intelligence can help reduce the cost and the amount of product failures in regard to drug development and creation.
 
view
download pdf
Standardising Conditions for Extractables Testing

Exhaustive Extraction

Simone Carrara and Michele Vasso at Eurofins illustrate the importance of extractables and leachables to ensure drug efficacy, and that the product remains in optimal condition to interact with the patient.
 
view
download pdf
bullet Stem Cell Research
Stem Cell Therapy

Recombinant Human Albumin

Cryopreservation and stem cell therapies are facing major changes and advancements, Dr Phil Morton and Dr Daniel Shelly at Albumedix discuss how albumin is useful across the cell therapy value chain.


 
view
download pdf
Live Cell Transport

The Rising Star

The way in which we transport existing cell shipments is continuously being optimised, and Dr Corné Swart at Cellbox Solutions looks into these new devices that allow cells to survive compared to traditional methods.
 
view
download pdf
bullet
rare diseases
Orphan Drugs and Rare Diseases

Patient Voices in the Industry

When considering the development of orphan drugs, the patients that suffer from the diseases and help process drug development in clinical trials also have to be considered, write William C Maier and Kelly Franchetti at ICON.
 
view
download pdf
bullet
dna and rna sequencing
Biopharmaceutical Applications

The Advantages of Long-Read Sequencing

Jonas Korlach at Pacific Biosciences discusses the improvements in long-read sequencing technology, and the applications it may have in the discovery of new drugs.
 
view
download pdf
Advances in Oncology

Advancing Liquid Biopsies

Mark Li at Resolution Bioscience examines why liquid biopsies are now becoming more commonly used compared to tissue biopsies.
 
view
download pdf
bullet
cannabis-based drugs
The Potential of Medical Cannabis

Budding Opportunities for Pharma

Shifting attitudes towards cannabis-based medicines are making them more appealing to drug developers, which will in turn help patients who need these drugs, writes Callum McGuinn at Mewburn Ellis.
 
view
download pdf
The Future of Clinical Research on Medical Cannabis

Trial by Fire

Dr Mark A Ware at Canopy Growth Corporation describes the changes in drug policy in recent times surrounding cannabis-based drugs, and the advantages they may have in treating patients.
 
view
download pdf
   
spacer


Published quarterly in
January, April,
July, and October

News and Press Releases

New IATA Guidance Prepares for Global Vaccine Distribution

The International Air Transport Association (IATA) released guidance to ensure that the air cargo industry is ready to support the large-scale handling, transport and distribution of a COVID-19 vaccine. IATA’s Guidance for Vaccine and Pharmaceutical Logistics and Distribution provides recommendations for governments and the logistics supply chain in preparation for what will be the largest and most complex global logistics operation ever undertaken.
More info >>

White Papers

The Impact of Components on Drug Quality and Risk Mitigation

West Pharmaceutical Services, Inc.

Expectations for quality by regulatory agencies are increasing at a very fast pace, especially for prefilled drug delivery formats, thanks to increased focus on reducing risk to patient safety. The trend has resulted in delays for new drug applications, more recalls of marketed products and even drug shortages if the container system and drug contents are suspect for quality issues. The pharmaceutical market is now requiring manufacturers of containers and components to meet new expectations with a quality culture and very high product reliability. The need to bridge the gap and provide superior quality products has been a driver for manufacturing technology investments, more robust control strategies and the introduction of next generation elastomer components.
More info >>

Industry Events

12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology

8-11 February 2021, Vienna, Austria

In continuation of the very successful scientific meetings in Budapest, Paris, Berlin, Florence, Geneva, Barcelona, Malta, Istanbul, Lisbon, Glasgow and Granada, the 12th PBP World will be held in Vienna from 8-11 Feb 2021. This every two year held conference has gained an ever increasing impact among the pharmaceutical scientists: With up to 1000 submitted abstracts and about 1300 participants it has become a well-established major meeting, attracting scientists from all over the world.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement